20xx年醫(yī)學(xué)專題—創(chuàng)傷性凝血病診治策略-文庫吧
2024-11-05 01:19 本頁面
【正文】 試驗陽性，或血漿FDP20mg/L（肝病60mg/L）或血漿DD水平較正常增高4倍以上（陽性）。 4.PT延長或縮短3s以上（肝病5s），APTT自然延長或縮短10s以上。 5.ATⅢ:A80pg/ml或凝血酶調(diào)節(jié)蛋白（TM）較正常增高2倍以上。,二、實驗(sh237。y224。n)診斷,10,第十頁，共二十九頁。,ISTH（國際血栓與止血(zhǐ xu232。)學(xué)會）,DIC 專業(yè)委員會根據(jù)體內(nèi)穩(wěn)定調(diào)節(jié)功能紊亂情況，將DIC 分為兩類： (1)非顯性DIC (NonOvert DIC)，指止血機制處于代償狀態(tài)(zhu224。ngt224。i)的DIC，即preDIC； (2)顯性DIC（Overt DIC），指止血機制處于失代償狀態(tài)的DIC ，即臨床典型DIC 。,11,第十一頁，共二十九頁。,ISTH Diagnostic Scoring System for DIC,Scoring system for overt DIC Risk assessment: Does the patient have an underlying disorder known to be associated with overt DIC? If yes: proceed If no: do not use this algorithm Order global coagulation tests (PT, platelet count, fibrinogen, fibrin related marker) Score the test results ? Platelet count (100 109/l = 0, 3 but 6 s = 2) ? Fibrinogen level (1 g/l = 0, 1 g/l = 1) Calculate score: ≥5 compatible with overt DIC: repeat score daily 5 suggestive for nonovert DIC: repeat next 1–2 d,12,第十
環(huán)評公示相關(guān)推薦
鄂ICP備17016276號-1